GE HealthCare attends ACC.26; showcases Photonova Spectra with U.S. FDA 510(k) clearance

Reuters
Yesterday
GE HealthCare attends ACC.26; showcases Photonova Spectra with U.S. FDA 510(k) clearance
  • GE HealthCare said it will showcase its cardiology portfolio at ACC.26, including AI-enabled imaging technologies and advanced software solutions.
  • The company plans to highlight the U.S. FDA 510(k) cleared Photonova Spectra photon-counting CT system and the ReadyFix fleet management solution enabled to work with MAC VU360 resting ECG workstations.
  • It also cited a U.S. agreement with Gentuity to connect customers with Gentuity HF-OCT and the Vis-Rx PRIME Micro-Imaging Catheter for interventional cardiology procedures.
  • The company said it will engage onsite at ACC.26 at booth #1726.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GE HealthCare Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603250900BIZWIRE_USPR_____20260325_BW159644) on March 25, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10